Strta Skn Scnces (SSKN)


Focuses on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The company's flagship product, MelaFind, features a hand-held imaging device.

View SEC Filings from SSKN instead.
Filers who had this stock in their top 10: 0
13F Filers holding this stock: 24
Aggregate shares on 12/31/2015: 2,712,818
Aggregate shares on 09/30/2015: 2,465,126
Percent change: 10.05%
Funds creating new positions: 7
Funds Adding to an existing position: 4
Funds closing out their position: 7
Funds reducing their position: 4
View recent insider trading info

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 12/31/2015

Subscription required

Click here to report any possible errors with this stock listing.

Elevate your investments

or Learn more